213 related articles for article (PubMed ID: 26705026)
1. CHCHD2 gene mutations in familial and sporadic Parkinson's disease.
Shi CH; Mao CY; Zhang SY; Yang J; Song B; Wu P; Zuo CT; Liu YT; Ji Y; Yang ZH; Wu J; Zhuang ZP; Xu YM
Neurobiol Aging; 2016 Feb; 38():217.e9-217.e13. PubMed ID: 26705026
[TBL] [Abstract][Full Text] [Related]
2. CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study.
Funayama M; Ohe K; Amo T; Furuya N; Yamaguchi J; Saiki S; Li Y; Ogaki K; Ando M; Yoshino H; Tomiyama H; Nishioka K; Hasegawa K; Saiki H; Satake W; Mogushi K; Sasaki R; Kokubo Y; Kuzuhara S; Toda T; Mizuno Y; Uchiyama Y; Ohno K; Hattori N
Lancet Neurol; 2015 Mar; 14(3):274-82. PubMed ID: 25662902
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of CHCHD2 gene in Chinese Han familial essential tremor patients and familial Parkinson's disease patients.
Gao C; Chen YM; Sun Q; He YC; Huang P; Wang T; Li DH; Liang L; Liu J; Xiao Q; Chen SD
Neurobiol Aging; 2017 Jan; 49():218.e9-218.e11. PubMed ID: 27814991
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of the CHCHD2 gene in a cohort of Chinese patients with Parkinson disease.
Wu H; Lu X; Xie F; Cen Z; Zheng X; Luo W
Neurosci Lett; 2016 Aug; 629():116-118. PubMed ID: 27353515
[TBL] [Abstract][Full Text] [Related]
5. Mutation analysis of CHCHD2 in Canadian patients with familial Parkinson's disease.
Zhang M; Xi Z; Fang S; Ghani M; Sato C; Moreno D; Liang Y; Lang AE; Rogaeva E
Neurobiol Aging; 2016 Feb; 38():217.e7-217.e8. PubMed ID: 26639156
[TBL] [Abstract][Full Text] [Related]
6. Genetic analysis of CHCHD2 gene in Chinese Parkinson's disease.
Li NN; Wang L; Tan EK; Cheng L; Sun XY; Lu ZJ; Li JY; Zhang JH; Peng R
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1148-1152. PubMed ID: 27626775
[TBL] [Abstract][Full Text] [Related]
7. Lack of CHCHD2 mutations in Parkinson's disease in a Taiwanese population.
Fan TS; Lin HI; Lin CH; Wu RM
Neurobiol Aging; 2016 Feb; 38():218.e1-218.e2. PubMed ID: 26725463
[TBL] [Abstract][Full Text] [Related]
8. CHCHD2 mutational screening in Brazilian patients with familial Parkinson's disease.
Voigt DD; Nascimento CM; de Souza RB; Cabello Acero PH; Campos Júnior M; da Silva CP; Pereira JS; Rosso AL; Araujo Leite MA; Vasconcellos LFR; Della Coletta MV; da Silva DJ; Nicaretta DH; Gonçalves AP; Dos Santos JM; Calassara V; Santos-Rebouças CB; Pimentel MMG
Neurobiol Aging; 2019 Feb; 74():236.e7-236.e8. PubMed ID: 30342766
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of CHCHD2 gene in Chinese familial Parkinson's disease.
Liu Z; Guo J; Li K; Qin L; Kang J; Shu L; Zhang Y; Wei Y; Yang N; Luo Y; Sun Q; Xu Q; Yan X; Tang B
Neurobiol Aging; 2015 Nov; 36(11):3117.e7-3117.e8. PubMed ID: 26343503
[TBL] [Abstract][Full Text] [Related]
10. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
[TBL] [Abstract][Full Text] [Related]
11. Mutational scanning of the CHCHD2 gene in Han Chinese patients with Parkinson's disease and meta-analysis of the literature.
Yang X; Zhao Q; An R; Zheng J; Tian S; Chen Y; Xu Y
Parkinsonism Relat Disord; 2016 Aug; 29():42-6. PubMed ID: 27269965
[TBL] [Abstract][Full Text] [Related]
12. Analysis of CHCHD2 gene in familial Parkinson's disease from Calabria.
Gagliardi M; Iannello G; Colica C; Annesi G; Quattrone A
Neurobiol Aging; 2017 Feb; 50():169.e5-169.e6. PubMed ID: 27839905
[TBL] [Abstract][Full Text] [Related]
13. Genetic analysis of the CHCHD2 gene in Chinese patients with familial essential tremor.
Wu H; Lu X; Cen Z; Xie F; Zheng X; Chen Y; Luo W
Neurosci Lett; 2016 Nov; 634():104-106. PubMed ID: 27717833
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of CHCHD2 and CHCHD10 in Italian patients with Parkinson's disease.
Rubino E; Brusa L; Zhang M; Boschi S; Govone F; Vacca A; Gai A; Pinessi L; Lopiano L; Rogaeva E; Rainero I
Neurobiol Aging; 2017 May; 53():193.e7-193.e8. PubMed ID: 28108040
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of CHCHD2 in a southern Spanish population.
Tejera-Parrado C; Jesús S; Huertas-Fernández I; Bernal-Bernal I; Bonilla-Toribio M; Córdoba-Tevar I; Abreu-Rodríguez I; Carrillo F; Bernal-Escudero M; Vargas-González L; Carballo M; Gómez-Garre P; Mir P
Neurobiol Aging; 2017 Feb; 50():169.e1-169.e2. PubMed ID: 27839904
[TBL] [Abstract][Full Text] [Related]
16. CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61I.
Mao C; Wang H; Luo H; Zhang S; Xu H; Zhang S; Rosenblum J; Wang Z; Zhang Q; Tang M; Shepard MJ; Wang X; Wang Y; Zhuang Z; Shi C; Xu Y
Neurobiol Aging; 2019 Mar; 75():38-41. PubMed ID: 30530185
[TBL] [Abstract][Full Text] [Related]
17. PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction.
Zhou W; Ma D; Sun AX; Tran HD; Ma DL; Singh BK; Zhou J; Zhang J; Wang D; Zhao Y; Yen PM; Goh E; Tan EK
Hum Mol Genet; 2019 Apr; 28(7):1100-1116. PubMed ID: 30496485
[TBL] [Abstract][Full Text] [Related]
18. Mutations in CHCHD2 cause α-synuclein aggregation.
Ikeda A; Nishioka K; Meng H; Takanashi M; Hasegawa I; Inoshita T; Shiba-Fukushima K; Li Y; Yoshino H; Mori A; Okuzumi A; Yamaguchi A; Nonaka R; Izawa N; Ishikawa KI; Saiki H; Morita M; Hasegawa M; Hasegawa K; Elahi M; Funayama M; Okano H; Akamatsu W; Imai Y; Hattori N
Hum Mol Genet; 2019 Dec; 28(23):3895-3911. PubMed ID: 31600778
[TBL] [Abstract][Full Text] [Related]
19. Varied pathological and therapeutic response effects associated with CHCHD2 mutant and risk variants.
Tio M; Wen R; Lim YL; Zukifli ZHB; Xie S; Ho P; Zhou Z; Koh TW; Zhao Y; Tan EK
Hum Mutat; 2017 Aug; 38(8):978-987. PubMed ID: 28432706
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders.
Ogaki K; Koga S; Heckman MG; Fiesel FC; Ando M; Labbé C; Lorenzo-Betancor O; Moussaud-Lamodière EL; Soto-Ortolaza AI; Walton RL; Strongosky AJ; Uitti RJ; McCarthy A; Lynch T; Siuda J; Opala G; Rudzinska M; Krygowska-Wajs A; Barcikowska M; Czyzewski K; Puschmann A; Nishioka K; Funayama M; Hattori N; Parisi JE; Petersen RC; Graff-Radford NR; Boeve BF; Springer W; Wszolek ZK; Dickson DW; Ross OA
Neurology; 2015 Dec; 85(23):2016-25. PubMed ID: 26561290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
